Grandeur Peak Global Advisors’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-15,036
Closed -$1.07M 109
2025
Q3
$1.07M Sell
15,036
-7,129
-32% -$475K 0.14% 81
2025
Q2
$1.33M Buy
22,165
+10,892
+97% +$597K 0.16% 76
2025
Q1
$592K Buy
11,273
+6,041
+115% +$339K 0.07% 96
2024
Q4
$288K Buy
+5,232
New +$275K 0.03% 122
2016
Q4
Sell
-106,935
Closed -$1.82M 108
2016
Q3
$1.82M Buy
+106,935
New +$1.98M 0.35% 61

Other funds holding IRMD

Grandeur Peak Global Advisors's IRMD Position: Q4 2025 in Review

Grandeur Peak Global Advisors sold out of iRadimed (IRMD) in Q4 2025, closing a stake of 15,036 shares — an estimated $1.07M sold.

Grandeur Peak Global Advisors first reported a position in IRMD in Q3 2016 and held it in 5 quarters. The position peaked at $1.82M in Q3 2016. 217 funds tracked by Wall St. Rank hold IRMD as of Q4 2025.

  • Grandeur Peak Global Advisors reported no remaining iRadimed position as of Q4 2025 after selling out during the quarter.
  • Grandeur Peak Global Advisors sold 15,036 iRadimed shares in Q4 2025, an estimated $1.07M.
  • Grandeur Peak Global Advisors first reported a position in iRadimed in Q3 2016 and held it in 5 quarters.
  • Grandeur Peak Global Advisors's iRadimed position peaked at $1.82M in Q3 2016.
  • 217 funds tracked by Wall St. Rank held iRadimed as of Q4 2025.

Based on Grandeur Peak Global Advisors's 13F filing for Q4 2025, filed 13 Feb 2026.